https://www.selleckchem.com/pr....oducts/heparan-sulfa
043) and tumor size (P less then 0.001) in patients with residual tumors. In patients with low-grade and clear cell carcinomas and a tumor size less then 1.35 cm, the probability of being in the low-PET group was 47.6%. In such patients, major parts of the residual tumors showed low 18F-FDG uptake, similar to that in patients with no residual tumors. Conclusion SUVmax was the lone predictive value for the presence of residual tumors after curettage in patients with endometrial cancer. Lesion SUVmax greater than 5 suggested a hig
Like
Comment
Share
